LC-MS/MS |
Doxorubicin / doxorubinicol, sunitinib, vandetanib,irinotecan (CPT-11, SN38, SN38-G) |
Homogenized tissue or biopsy |
✓ |
X |
X |
[7, 62, 65, 73, 121–123] |
LC-FD |
Doxorubicin |
Homogenized tissue |
✓ |
X |
X |
[15] |
Fluorescence microscopy |
Doxorubicin, sunitinib |
Tumor section |
✓ |
✓ |
X |
[7, 15, 95, 113] |
Autoradiography |
14C doxorubicin |
Whole-body section (rat) |
✓ |
✓ |
X |
[124] |
Atomic absorption spectroscopy |
Doxorubicin / doxorubinicol |
Homogenized tissue |
✓ |
X |
X |
[102] |
Microspectrofluorimetry |
Doxorubicin |
Tissue section |
✓ |
✓ |
X |
[103, 108, 122] |
Infra-red microspectroscopy |
Doxorubicin, ibuprofen |
Tissue section |
X |
X |
✓ |
[103, 125] |
Mass spectroscopy imaging |
Sunitinib and metabolites |
Tissue section |
✓ |
✓ |
X |
[113] |
Atomic fluorescence |
Arsenic trioxide |
Homogenized tissue |
✓ |
X |
X |
[126] |